High-Altitude Pulmonary Edema Management in a Special Operator
Abstract
This case report delves into the challenges in diagnosis and management of a 30-year-old Army Special Forces officer who experienced respiratory distress during high-altitude training in Nepal, where he gained 3,000m in elevation over 3 days. Notably, the patient was prophylactically treated with acetazolamide but did not receive nifedipine or tadalafil. At an elevation of 13,550 feet (4,130m), the patient developed classic high-altitude pulmonary edema (HAPE) symptoms as well as concomitant respiratory symptomatology of breathlessness and worsening productive cough. The complexity of this case lay in managing HAPE in a remote, resource-limited environment with a small rescue window. We analyze the treatment alternatives used and ones not used, such as the portable hyperbaric chamber, and emphasize the necessity for standard-ized HAPE prophylaxis in appropriate personnel to prevent disruption to mission and loss of operational capabilities.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Protective effects of tadalafil and N-acetyl cysteine therapy on cisplatin-induced testicular toxicity
- The Use of Generative AI for Scientific Literature Searches for Systematic Reviews: ChatGPT and Microsoft Bing AI Performance Evaluation
- Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons
- Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent
- Effectiveness of Low-Intensity Extracorporeal Shock Wave Therapy in Erectile Dysfunction: An Analysis of Sexual Function and Penile Hardness at Erection: An Umbrella Review
- Molecular Docking of Silymarin as a Ligand for Aromatase Enzyme and HIV-1 Reverse Transcriptase Using Molegro Virtual Docker
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.